Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01
Published November 10, 2021 · Recall initiated: October 19, 2021
Summary
FDA records drug Class I recall D-0093-2022, published November 10, 2021 and initiated October 19, 2021. Recalling firm: MERCK SHARP & DOHME CORP; Status: Terminated; Reported quantity: 76,163 vials; Lot: Lot #: 934778, Exp. Date Jun 2022. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Identified as Glass Particles
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- MERCK SHARP & DOHME CORP
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 934778, Exp. Date Jun 2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAJanumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles perApril 13, 2022
- FDAMethocarbamol 500mg Tablet, packaged in a) #30 count (NDC 7133517952), b) #60 count (NDC 7133517954), and c)November 10, 2021
- FDAAsian Pears 5Kg, YW Brand; 14 pears per caseNovember 10, 2021
- FDAIrbesartan and Hydrochlorothiazide Tablets USP, 300/12.5 mg a) 30 count (NDC 68180-414-06) and b) 90 countNovember 10, 2021
- FDAFresh From Meijer, Honey Ham & Cheddar Pretzel Roll Sliders, 6.24 Oz., Plastic clam-shell - clear lid, blackNovember 10, 2021
- FDAIrbesartan Tablets USP, 150 mg a) 30 count (NDC 68180-411-06) and b) 90 count (NDC 68180-411-09) bottles, RxNovember 10, 2021
Questions about this recall
Was Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01 recalled?
Yes. FDA published recall D-0093-2022 on November 10, 2021. Reported hazard: Presence of Particulate Matter: Identified as Glass Particles
What should I do if I have this product?
Voluntary: Firm initiated · Press Release